warfarin and Muscle-Weakness

warfarin has been researched along with Muscle-Weakness* in 7 studies

Reviews

1 review(s) available for warfarin and Muscle-Weakness

ArticleYear
Sneddon's syndrome: a case report.
    Cutis, 2001, Volume: 67, Issue:3

    We report a case of Sneddon's syndrome with the triad of livedo reticularis, hypertension, and neurologic symptoms. The procedures for diagnosis and the tests to delineate clotting abnormalities are examined.

    Topics: Adult; Anticoagulants; Cerebral Infarction; Diagnosis, Differential; Humans; Hypesthesia; Magnetic Resonance Angiography; Male; Muscle Weakness; Sneddon Syndrome; Warfarin

2001

Other Studies

6 other study(ies) available for warfarin and Muscle-Weakness

ArticleYear
Renal cholesterol crystal embolism in the setting of warfarin use.
    BMJ case reports, 2019, Aug-21, Volume: 12, Issue:8

    A 73-year-old man presented for evaluation of weakness and black tarry stools that occurred 1 day prior to admission. His medical history is significant for diabetes mellitus, stage 3 chronic kidney disease and deep vein thrombosis on warfarin. He was admitted to the hospital and was found to have acute kidney injury and gastrointestinal bleeding due to a supratherapeutic International Normalized Ratio. His hospital course was complicated by persistent decline in his renal function. He was given intravenous fluid resuscitation, fresh frozen plasma and packed red blood cells for his acute blood loss anaemia. Urinalysis was consistent with acute tubular necrosis. Given the persistent rise in creatinine, a kidney biopsy was obtained, and was significant for mild inflammatory changes, without evidence of vasculitis or allergic interstitial nephritis. Histopathological examination with tissue fixation revealed cholesterol embolisation. Given that he had no recent endovascular procedure or instrumentation, this atheroembolic event was attributed to his warfarin use.

    Topics: Aged; Anticoagulants; Diagnosis, Differential; Embolism, Cholesterol; Gastrointestinal Hemorrhage; Humans; Male; Muscle Weakness; Nephritis, Interstitial; Venous Thrombosis; Warfarin

2019
4-Factor Prothrombin Complex Concentrate Administration via Intraosseous Access for Urgent Reversal of Warfarin.
    The Journal of emergency medicine, 2019, Volume: 57, Issue:1

    Vitamin K antagonist (VKA) reversal in patients with acute major bleeding and coagulopathy is an example of an urgent intervention in the emergency department. Intravenous (IV) prothrombin complex concentrate (PCC) may reverse VKA-induced coagulopathy in <30 min. In patients lacking IV access, effective PCC administration becomes problematic. No previous case reports have documented PCC infusion via intraosseous (IO) or alternative routes in this setting.. A 74-year-old man presented to the emergency department (ED) after a head injury, with sudden onset of left-sided facial droop, weakness, hypertension, and dizziness. Initial vital signs include blood pressure of 221/102 mm Hg, a heart rate of 75 beats/min, and oxygen saturation of 96% on room air. Warfarin 3 mg once daily was among his medications. His international normalized ratio (INR) was 3.9 with a computed tomography scan showing intraparenchymal hemorrhage in the right temporal lobe. Multiple attempts for IV access at various sites were unsuccessful. Therefore, IO access was established. Because of his prolonged prothrombin time, elevated INR, and intraparenchymal hemorrhage, the decision was made to use 4-factor PCC to reverse the supratherapeutic INR. The INR normalized as an emergent right parietal hematoma evacuation was performed. After an inpatient course, the patient was eventually discharged. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: VKAs, like warfarin, are commonly prescribed medications. When life-threatening hemorrhage is present, rapid reversal of a VKA-induced coagulopathy may be a life-saving therapy. In the event that IV access has not been established, we have demonstrated that IO access is a viable alternative route for PCC administration.

    Topics: Aged; Anticoagulants; Blood Coagulation Factors; Dizziness; Hemorrhage; Humans; Hypertension; Infusions, Intraosseous; Male; Muscle Weakness; Time Factors; Warfarin

2019
Vein of trolard sign on noncontrast computed tomography in Behcet's disease.
    Acta medica academica, 2014, Volume: 43, Issue:1

    Topics: Anticoagulants; Behcet Syndrome; Diagnosis, Differential; Epilepsy, Tonic-Clonic; Headache; Heparin; Humans; Male; Middle Aged; Muscle Weakness; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed; Warfarin

2014
Subacute proximal leg weakness after a minor traffic accident in a patient treated with anticoagulants.
    BMJ case reports, 2012, May-23, Volume: 2012

    One day after a minor accident, an 85-year-old man developed headache and proximal left leg weakness. He was on warfarin due to atrial fibrillation. On hospital admission, a right posterior parasagittal subdural haematoma that was visualised on CT was considered as cause of all symptoms. Although no surgical intervention was performed he stayed for 2 weeks in a neurosurgical ward. Clinical deterioration occurred within the first days as he was not able to stand on his left leg or rise up from the sitting position. Headache had ceased, but the patient reported low abdominal pain. This condition remained stable for over 2 months although haematoma size decreased significantly. He was then examined for the first time by a neurologist who documented typical clinical features of femoral nerve palsy. Pelvic CT established the diagnosis of traumatic iliacus- and iliopsoas-muscle haematoma under anticoagulants as cause of subacute femoral mononeuropathy.

    Topics: Accidents, Traffic; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Femoral Nerve; Hematoma; Humans; Leg Injuries; Male; Muscle Weakness; Tomography, X-Ray Computed; Warfarin

2012
Anterior spinal artery infarction at the cervicomedullary junction.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2006, Volume: 33, Issue:4

    Topics: Aged, 80 and over; Anticoagulants; Atrial Flutter; Cervical Vertebrae; Diabetes Mellitus, Type 2; Humans; Infarction; Magnetic Resonance Angiography; Male; Muscle Weakness; Spinal Cord; Vertebral Artery; Warfarin

2006
[Muscle weakness].
    Praxis, 2003, Feb-05, Volume: 92, Issue:6

    A 31-year old cook suffered from episodes with muscular weakness since 3 weeks. These episodes resolved, at times, spontaneously and completely after a few hours. The weakness affected mainly the muscles of trunk and proximal extremities. Investigation of the patient revealed flaccid tetraparesis with diminished tendon reflexes, however, cranial muscles were not affected. Mental function and sensibility were intact. These findings were consistent with hypopotassemic periodic paralysis rather than a neurological or psychiatric disease. Serum potassium was determined as 1.8 mmol/l. Moreover, the patient suffered from atrial fibrillation. Grave's disease could be identified as the underlying cause of hypopotasemic periodic paralysis and atrial fibrillation. Further manifestations of primary hyperthyroidism were nervousness, diarrhea and weight loss of 5 kg observed during the previous months. The symptoms resolved under treatment with potassium, betablocker and thyrostatic agents. The patient was treated with warfarin because of atrial fibrillation and finally underwent electroconversion.

    Topics: Adrenergic beta-Antagonists; Adult; Anticoagulants; Atrial Fibrillation; Diagnosis, Differential; Electric Countershock; Graves Disease; Humans; Hypokalemia; Male; Muscle Weakness; Potassium; Time Factors; Warfarin

2003